CA3073442A1 - Procede d'obtention rapide de concentrations therapeutiques de zolmitriptan pour le traitement de migraines et de cephalees de horton - Google Patents

Procede d'obtention rapide de concentrations therapeutiques de zolmitriptan pour le traitement de migraines et de cephalees de horton Download PDF

Info

Publication number
CA3073442A1
CA3073442A1 CA3073442A CA3073442A CA3073442A1 CA 3073442 A1 CA3073442 A1 CA 3073442A1 CA 3073442 A CA3073442 A CA 3073442A CA 3073442 A CA3073442 A CA 3073442A CA 3073442 A1 CA3073442 A1 CA 3073442A1
Authority
CA
Canada
Prior art keywords
zolmitriptan
patch
coating
hours
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA3073442A
Other languages
English (en)
Other versions
CA3073442C (fr
Inventor
Mahmoud Ameri
Donald Kellerman
Yi Ao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emergex USA Corp
Original Assignee
Zosano Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zosano Pharma Corp filed Critical Zosano Pharma Corp
Priority to CA3223555A priority Critical patent/CA3223555A1/fr
Publication of CA3073442A1 publication Critical patent/CA3073442A1/fr
Application granted granted Critical
Publication of CA3073442C publication Critical patent/CA3073442C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

L'invention concerne des compositions, des dispositifs et des méthodes utilisant des concentrations thérapeutiques d'un triptan pour le traitement de la migraine. L'invention concerne également des méthodes et des appareils pour l'administration du zolmitriptan permettant d'obtenir un Tmax en un délai aussi rapide que 2 minutes et en moins de 30 minutes chez la majorité des sujets.
CA3073442A 2017-08-23 2017-08-23 Procede d'obtention rapide de concentrations therapeutiques de zolmitriptan pour le traitement de migraines et de cephalees de horton Active CA3073442C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3223555A CA3223555A1 (fr) 2017-08-23 2017-08-23 Procede d'obtention rapide de concentrations therapeutiques de zolmitriptan pour le traitement de migraines et de cephalees de horton

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2017/048258 WO2019040063A1 (fr) 2017-08-23 2017-08-23 Procédé d'obtention rapide de concentrations thérapeutiques de zolmitriptan pour le traitement de migraines et de céphalées de horton

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA3223555A Division CA3223555A1 (fr) 2017-08-23 2017-08-23 Procede d'obtention rapide de concentrations therapeutiques de zolmitriptan pour le traitement de migraines et de cephalees de horton

Publications (2)

Publication Number Publication Date
CA3073442A1 true CA3073442A1 (fr) 2019-02-28
CA3073442C CA3073442C (fr) 2024-02-06

Family

ID=59829462

Family Applications (2)

Application Number Title Priority Date Filing Date
CA3223555A Pending CA3223555A1 (fr) 2017-08-23 2017-08-23 Procede d'obtention rapide de concentrations therapeutiques de zolmitriptan pour le traitement de migraines et de cephalees de horton
CA3073442A Active CA3073442C (fr) 2017-08-23 2017-08-23 Procede d'obtention rapide de concentrations therapeutiques de zolmitriptan pour le traitement de migraines et de cephalees de horton

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA3223555A Pending CA3223555A1 (fr) 2017-08-23 2017-08-23 Procede d'obtention rapide de concentrations therapeutiques de zolmitriptan pour le traitement de migraines et de cephalees de horton

Country Status (8)

Country Link
EP (1) EP3672570A1 (fr)
JP (2) JP7219384B2 (fr)
KR (2) KR20210155817A (fr)
CN (1) CN111050749A (fr)
AU (1) AU2017428907B2 (fr)
CA (2) CA3223555A1 (fr)
IL (1) IL272776B2 (fr)
WO (1) WO2019040063A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3989970A4 (fr) * 2019-06-28 2023-06-07 PassPort Technologies, Inc. Système de distribution de micro-porosités de triptan

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3416618A1 (fr) 2016-02-19 2018-12-26 ZP Opco, Inc. Procédé pour obtenir rapidement des concentrations thérapeutiques de triptans pour le traitement de migraines
US11660264B2 (en) 2017-08-23 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
US11660265B2 (en) 2018-06-28 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
WO2020245667A1 (fr) * 2019-06-06 2020-12-10 Kindeva Drug Delivery L.P. Support de microréseau destiné à un applicateur de microréseau
CN114699510A (zh) * 2021-12-29 2022-07-05 浙江湃肽生物有限公司 一种司美格鲁肽微针阵列及其制备方法
CN115887903A (zh) * 2022-12-15 2023-04-04 太平洋康泰科学仪器（济南）有限公司 微针贴片给药组件及给药方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080646A (en) 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5147296A (en) 1988-10-03 1992-09-15 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5169382A (en) 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
CA2253549C (fr) 1996-06-18 2005-10-25 Alza Corporation Dispositif d'amelioration d'apport ou d'echantillonnage d'agents transdermiques
US5741554A (en) 1996-07-26 1998-04-21 Bio Dot, Inc. Method of dispensing a liquid reagent
US5738728A (en) 1996-07-26 1998-04-14 Bio Dot, Inc. Precision metered aerosol dispensing apparatus
US5743960A (en) 1996-07-26 1998-04-28 Bio-Dot, Inc. Precision metered solenoid valve dispenser
US5916524A (en) 1997-07-23 1999-06-29 Bio-Dot, Inc. Dispensing apparatus having improved dynamic range
DE69831268T2 (de) 1997-12-11 2006-03-09 Alza Corp., Palo Alto Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
AU739616B2 (en) 1997-12-11 2001-10-18 Alza Corporation Device for enhancing transdermal agent flux
DK1037687T3 (da) 1997-12-11 2009-01-26 Alza Corp Anordning til at forbedre et middels transdermale strömning
US6091975A (en) 1998-04-01 2000-07-18 Alza Corporation Minimally invasive detecting device
DE60024312T2 (de) 1999-12-10 2006-08-17 Alza Corp., Mountain View Transdermale Wirkstoffabgabe von makromolekularen Wirkstoffen und Vorrichtung hierfür
BR0114634A (pt) 2000-10-13 2004-01-27 Alza Corp Aplicador por impacto de disposição de microlâmina
RU2278623C2 (ru) 2000-10-13 2006-06-27 Алза Корпорейшн Держатель микровыступающего элемента для силового аппликатора
BR0114629A (pt) 2000-10-13 2004-01-20 Alza Corp Aparelho e método para a perfuração da pele com microprojeções
US7419481B2 (en) 2000-10-13 2008-09-02 Alza Corporation Apparatus and method for piercing skin with microprotrusions
BR0114909A (pt) 2000-10-26 2004-02-03 Alza Corp Dispositivos de distribuição de drogas transdérmicas possuindo microprotuberâncias revestidas
US6855372B2 (en) 2001-03-16 2005-02-15 Alza Corporation Method and apparatus for coating skin piercing microprojections
CA2444883A1 (fr) 2001-04-20 2002-10-31 Alza Corporation Reseau de micro-projections avec revetement contenant un principe benefique
ATE539687T1 (de) 2003-10-31 2012-01-15 Alza Corp Selbstbetätigter applikator für eine mikroprojektionsanordnung
EP1744683B1 (fr) 2004-05-13 2016-03-16 Alza Corporation Appareil et procédé pour la délivrance transdermique d'agents à base d'hormone parathyroïde
CA2680690A1 (fr) 2006-03-15 2007-09-20 Alza Corporation Appareil et procede d'administration transdermique d'agents hormonaux parathyroidiens destines a traiter ou prevenir l'osteopenie
WO2008115586A1 (fr) * 2007-03-21 2008-09-25 Alza Corporation Appareil et procédé d'administration transdermique d'un agoniste de triptane
JP6121734B2 (ja) * 2012-02-09 2017-04-26 久光製薬株式会社 マイクロニードル用ゾルミトリプタン含有コーティング組成物及びマイクロニードルデバイス
WO2015017561A1 (fr) 2013-07-30 2015-02-05 Zosano Pharma, Inc. Applicateur extra-plat de tampon de micro-aiguilles
EP3416618A1 (fr) * 2016-02-19 2018-12-26 ZP Opco, Inc. Procédé pour obtenir rapidement des concentrations thérapeutiques de triptans pour le traitement de migraines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3989970A4 (fr) * 2019-06-28 2023-06-07 PassPort Technologies, Inc. Système de distribution de micro-porosités de triptan

Also Published As

Publication number Publication date
CA3223555A1 (fr) 2019-02-28
KR20200032170A (ko) 2020-03-25
JP2023033378A (ja) 2023-03-10
JP2021500397A (ja) 2021-01-07
IL272776B1 (en) 2024-02-01
KR20210155817A (ko) 2021-12-23
EP3672570A1 (fr) 2020-07-01
KR102340393B1 (ko) 2021-12-17
AU2017428907A1 (en) 2020-03-05
JP7219384B2 (ja) 2023-02-08
CA3073442C (fr) 2024-02-06
CN111050749A (zh) 2020-04-21
IL272776A (en) 2020-04-30
AU2017428907B2 (en) 2021-12-16
WO2019040063A1 (fr) 2019-02-28
IL272776B2 (en) 2024-06-01

Similar Documents

Publication Publication Date Title
CA3073442C (fr) Procede d'obtention rapide de concentrations therapeutiques de zolmitriptan pour le traitement de migraines et de cephalees de horton
US11660264B2 (en) Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
US11839683B2 (en) Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
RU2282468C2 (ru) Устройство для трансдермальной доставки лекарственных средств, имеющее микровыступы с покрытием
US20040138610A1 (en) Active agent delivery device having composite members
US20230210762A1 (en) Transdermal drug delivery devices having psilocybin, lysergic acid diethylamide or 3,4-methylenedioxymethamphetamine coated microprotrusions
US11660265B2 (en) Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
US7455654B2 (en) Method and apparatus for reducing the incidence of tobacco use
JP2009542657A (ja) ゲルの形態でのロピニロール含有薬学的組成物、その使用
WO2008115586A1 (fr) Appareil et procédé d'administration transdermique d'un agoniste de triptane
US20230255881A1 (en) Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20200219

EEER Examination request

Effective date: 20200219

EEER Examination request

Effective date: 20200219

EEER Examination request

Effective date: 20200219

EEER Examination request

Effective date: 20200219

EEER Examination request

Effective date: 20200219

EEER Examination request

Effective date: 20200219

EEER Examination request

Effective date: 20200219

EEER Examination request

Effective date: 20200219

EEER Examination request

Effective date: 20200219